SCHEMBL29559926

SCHEMBL29559926

CC(C)(C)OC(=O)c1csc2c(Br)cc(C=O)nc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22866574 1.00 HPGDS (0.31) HPGDS
SCHEMBL22866471 0.83 L3MBTL1 (0.34) HPGDS
SCHEMBL28713249 0.81 PIM1 (0.39) —
SCHEMBL29661801 0.80 UGT8 (0.31) HPGDS
SCHEMBL22866572 0.80 UGT8 (0.31) HPGDS
SCHEMBL29661871 0.80 UGT8 (0.31) HPGDS
SCHEMBL22866552 0.80 UGT8 (0.31) HPGDS
SCHEMBL22866573 0.79 UGT8 (0.33) HPGDS
SCHEMBL22866554 0.78 PTPRB (0.33) —
SCHEMBL29561004 0.78 PTPRB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3994139-A1 EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS Effector Therapeutics Inc. (US) 2022-05-11 — — EP disclosed
CN-114269756-A 4-oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds inhibiting EIF4E 效应疗法股份有限公司 2022-04-01 — — CN disclosed
Send feedback